Skip to content
Study details
Enrolling now

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Mayo Clinic
NCT IDNCT06635980ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

120

Study length

about 9.4 years

Ages

18+

Sex

Female only

Locations

1 site in AZ

What this study is about

This trial is testing whether hypofractionated radiotherapy, given before (preoperative) or after (postoperative) breast surgery, can effectively treat non-metastatic breast cancer. The goal is to determine the outcomes and side effects of this treatment approach.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Receive Hypofractionated Radiation Therapy
  • 2.Survey Administration
  • 3.Take Chemotherapy
  • +3 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Incidence of grade 3 or higher radiation treatment (RT) related adverse events

Procedures

biopsy, diagnostic, surgery, imaging, radiation

Body systems

Oncology